The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. Insider Monkey finished processing 821 13F filings submitted by hedge funds and prominent investors. These filings show these funds’ portfolio positions as of March 31st, 2020. […] …read more […]
We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds’ and investors’ portfolio positions as of March 31st, near the height of the coronavirus market crash. In this article, we look at what those funds think […] …read more […]
MedMen Enterprises Inc. (CSE:MMEN) just released its latest quarterly report and things are not looking great… …read more […]
(Bloomberg) — Biotechnology stocks saw broad swings Friday morning as investors worked their way through a deluge of data from cancer drug developers presenting at the American Society of Clinical Oncology’s virtual annual meeting.Wall Street was quick to crown small-caps Adaptimmune Therapeutics Plc and Trillium Therapeutics Inc. as well as heavyweight AstraZeneca Plc among the early winners with shares rallying on the back of their respective updates. On the flip side, uninspiring results from Arvinas Inc.’s prostate cancer study and Aveo Pharmaceuticals Inc.’s kidney cancer trial drove investors to punish shares.Here’s a breakdown of some of ASCO’s biggest winners and …read more […]
Aircraft makers are circling Brazil’s Embraer weeks after Boeing ditched plans for a historic commercial aviation tie-up, people familiar with the matter said. Boeing axed plans to buy 80% of Embraer’s commercial unit in April, ending a planned move into regional jets that mirrored rival Airbus’ purchase in 2018 of a competing model developed by Canada’s Bombardier. China’s state-owned COMAC planemaker has voiced informal interest in co-operation with the world’s third-largest jetmaker, two of the people said. …read more […]
President Donald Trump is expected to make an announcement regarding relations between the U.S. and China on Friday. Arthur Dong, Georgetown University Professor, joins Yahoo Finance’s Alexis Christoforous and Brian Sozzi to discuss that more. …read more […]
(Bloomberg) — The scramble to jump on one of the hottest gold trades in years — by shipping bullion to New York — has sparked what may be one of the largest ever physical transfers of the metal.“The flows into New York are unprecedented,” said Allan Finn, global commodities director at logistics and security provider Malca-Amit. His company’s teams in New York have been working 24 hours a day to cope with demand while navigating lockdowns, flight disruptions and social distancing.Gold flooded into the U.S. in recent months as traders rushed to profit from an arbitrage caused by dislocations in …read more […]
As anti-police protests escalated overnight in Minneapolis, President Trump tweeted about the protests. For the first time, Twitter marked one of the President’s tweets with a warning for “glorifying violence”. Yahoo Finance’s Brian Sozzi, Alexis Christoforous, and Rick Newman discuss. …read more […]
The option, which is already available in a handful of cities in Australia, Africa, Europe and the Middle East, will cost $50 per hour. Fares for regular Uber rides are generally based on the level of demand and the trip distance. Uber said it decided to expand the hourly feature to the U.S. after riders requested an option for extended trips during the pandemic to avoid exposure to different drivers and vehicles when taking multiple trips in a confined time period. …read more […]
The Inari Medical IPO launched May 22, 2020. Investors immediately jumped on Inari stock. Its price soared to best opening-day gains of any IPO this year. And that’s a good sign to investors the markets are improving from coronavirus levels.
But is Inari Medical a good investment? Here’s what we know…
Inari IPO: The Business
Inari Medical is a medical device company. Bob Rosenbluth founded it in 2013. Inari develops products to treat venous diseases. Currently, the company offers two products, the ClotTriever and FlowTriever. According to the company…
“We believe the best way to treat VTE (venous thromboembolism) and improve the quality of …read more […]
Stock futures fell Friday morning, extending losses from the regular session Thursday as investors eyed renewed tensions between the U.S. and China. …read more […]
EU antitrust chief Margrethe Vestager denied on Friday that she was putting hurdles in the way of Lufthansa’s $10 billion government rescue, saying companies getting big capital injections from the state have to offset their competitive advantage. Vestager wants Lufthansa to permanently give up some take-off and landing slots at Frankfurt and Munich airports, where it commands a two-thirds market share, in return for giving the green light to the German government taking a 20% stake in the airline. Lufthansa’s board, however, has rejected her demands. …read more […]
Are you a doctor, lawyer, or other professional? How about a salaried employee?
If so, you’re in a trap. And you’ll never get out unless you listen to me today.
In my book Automatic Wealth, I talked about this “trap.” Here’s what I said…
At the end of the day, you are charging for your time. And if you want to make more money, there are only two ways to do it:
1. Charge more per hour.
2. Work more hours (though there are only so many hours you can work and still have a life).
Professionals and top executives, you may be surprised …read more […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
